Remeditex Ventures and Velocity Pharmaceutical Development(VPD)announced the signing of a collaboration agreement.

St. Jude Medical bought Endosense for USD331 million. St. Jude Medical Inc. recently acquired Endosense SA for USD 331 million to add to the former's electrophysiology portfolio.

Miami-based drug developer Opko Health, Inc. will enlist in Tel Aviv Stock Exchange to acquire Israeli drugmaker, Prolor Biotech, Inc.

The Singapore government disclosed plans of improving social programs to alleviate economic strains.

Lupin Ltd is set to expand its portfolio through strategic acquisitions and new product lines. Lupin Ltd, the pharmaceutical firm, is in the process of expanding its branded portfolio through the launch of pharmaceutical products.

China launched a fresh three-month slate to intensify its probe against rampant bribery in the medical services and pharmaceutical sectors in the country, according to the official Xinhua news agency.

It was announced that Parthenon acquired Bracket from Express Scripts Holding Company. Bracket announced via Press Release that it is no longer under the wing of Express Scripts Holding Company.

Fulcrum Equity Partners lead growth capital investments for outcome-based preventive health company, RivalHealth.

Private equity company EQT invested CHF 44 million in Swiss Smile. Nordic private equity firm EQT announced that it has backed Swiss dental chain Swiss Smile with a CHF 44 million investment.

MannKind Corp revealed that Afrezza proved to be effective in two late stage studies. MannKind Corp announced a major breakthrough in its diabetes therapy drug Afrezza.